期刊文献+

46例原发扁桃体非霍奇金淋巴瘤的临床分析 被引量:1

Clinical features of 46 patients with primary Non-Hodgkin's lymphoma of the tonsil
下载PDF
导出
摘要 目的总结原发扁桃体NHL的临床特点及治疗预后,探讨进一步改善预后和治疗后生存质量的可能途径。方法回顾性分析1996年10月~2002年11月46例初治原发扁桃体NHL患者的临床资料。I期和Ⅱ期患者42例(91.3%)主要接受放化疗联合治疗,Ⅲ期和Ⅳ期患者以化疗为主。46例患者中弥漫大B细胞型36例(78.26%),外周T细胞型5例(10.87%),惰性淋巴瘤3例(6.5%),间变大T细胞型和T淋巴母细胞型各1例。结果全组患者5年总生存率和无病生存率均为71.74%,Ⅰ期和Ⅱ期患者的5年生存率为78.57%。早期患者的生存率与原发耐药、复发和国际预后指数(international Prognostic index,IPI)评分有显著相关;而性别、年龄、病理类型、B症状、是否有巨块等对生存率均无显著性影响。结论原发于扁桃体的NHL绝大部分为Ⅰ期和Ⅱ期的早期患者,因此预后较好。病理类型以弥漫大B细胞型最为多见。C0x回归后分析显示在早期患者中原发耐药、复发和IPI>1是影响预后的主要因素。 Objective To investigate the clinical features of primary non-Hodgkin's lymphoma(NHL)of the tonsil, and to explore possible ways to improve the prognosis and quality of life of the patients after treatment.Methods Clinical dats of 46 patients with NHL of the tonsil,treated from October 1996 to November 2002 were retrospectively reviewed.42 (91.3%)were Stage Ⅰ-Ⅱ patients received radiochemotherapy-predominant treatment,whereas stage Ⅲ- Ⅳ patients received chemotherapy-predominant treatment,of the 46 cases,36(78.26%)were diffuse large B-cell subtype, 5(10.87%) were peripheral T-cell subtype, 3(6.5%) were indolent lymphoma, 1 was anaplastic large large T-cell lymphoma,and 1 was T lymphoblastic lymphoma,esults The5-year overall survival rate was 71.74% ,that of stage Ⅰ -Ⅱ patients was 78.57% .Cox regression multivariate analysis showed that the survival rate was correlated to the value of international prognostic index,(IPI),and whether the patient had primary refractory or relapsed disease, but was not correlated to sex, age, pathologic subtype, B symptoms, and bulky disease.Conclusion Most patients with NHL of the tonsil are at early stages, with good prognosis. Diffuse large B-cell lymphoma is the most common pathologic subtype. Primary refractory, relapse, and IPI〉I are independent prognostic factors.
出处 《江西医药》 CAS 2008年第9期881-883,共3页 Jiangxi Medical Journal
关键词 扁桃体肿瘤 非霍奇金淋巴瘤 化学疗法 放射疗法 预后 tonsil neoplasm Non-Hodgkin's lymphoma chenotherapy radiotherapy prognosis
  • 相关文献

参考文献8

  • 1Shima N, Kobashi Y, Tsutsui K,et al.Extranodal non-Hodgkin's lymphoma of the head and meck.Cancer,1990,66(6):1190.
  • 2Economopoulos T,Asprou N,Stathakis N.Primary extranodal non- Hodgkin's lymphoma of the head and necd.Oncology,1992,49(6):484.
  • 3Gustavsson A, Osterman B,Cavallin-Stahl E.A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma.Acta Oncol, 2003,42(5- 6):605.
  • 4袁智勇,李晔雄,赵路军,高远红,刘新帆,顾大中,钱图南,余子豪.鼻咽非霍奇金淋巴瘤的临床与预后分析[J].中华肿瘤杂志,2004,26(7):425-429. 被引量:16
  • 5Reyes F,Lepage E,Ganem G,et al.ACVBP versus CHOP plus radiotherapy for localized lymphoma.N Engl J Med,2005,352(12): 1197.
  • 6Shenkier T N,Voss N,Fairey R,et al.Brief chemotherapy and involvedregion irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Coumbia Cancer Agency.J Clin Oncol,2002,20(1):197.
  • 7Armitage J O,Carbone P P,Connors J M,et al.Treatment related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma .patiants.J Clin Oncol,2003,21(5):897.
  • 8Andre M, Mounier N,Leleu X,et al.Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen:a CELA cohort study on 2837 patients,Blood,2004:, 103(4):1222.

二级参考文献15

  • 1Atkins CD, Moore GE, Shipp MA, et al. The International Non-Hodgkin′s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin′s lymphoma.N Engl J Med, 1994,330: 574-575.
  • 2Aviles A, Delgado S, Ruiz H, et al. Treatment of non-Hodgkin′s lymphoma of Waldeyer′s ring: radiotherapy versus chemotherapy versus combined therapy. Eur J Cancer B Oral Oncol, 1996,32B: 19-23.
  • 3Ezzat AA, Ibrahim EM, El Weshi AN, et al. Localized non-Hodgkin′s lymphoma of Waldeyer′s ring: clinical features, management, and prognosis of 130 adult patients. Head Neck, 2001, 23: 547-558.
  • 4Harabuchi Y, Tsubota H, Ohguro S, et al. Prognostic factors and treatment outcome in non-Hodgkin′s lymphoma of Waldeyer′s ring.Acta Oncol, 1997,36: 413-420.
  • 5Liang R, Chiu E, Todd D, et al. Combined chemotherapy and radiotherapy for lymphoma of Waldeyer′s Ring. Oncology, 1991, 48:362-364.
  • 6Barton JH, Osborne BM, Butler JJ, et al. Non-Hodgkin′s lymphoma of the tonsil: a clinicopathologic study of 65 cases. Cancer, 1984, 53:86-95.
  • 7Makepeace AR, Fermont DC, Bennett MH. Non-Hodgkin′s lymphoma of the tonsil. Experience of treatment over a 27-year period. J Laryngol Otol, 1987, 101: 1151-1158.
  • 8Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin′s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer, 1998, 83:449-456.
  • 9Yu KH, Yu SC, Teo PM, et al. Nasal lymphoma: results of local radiotherapy with or without chemotherapy. Head Neck, 1997, 19:251-259.
  • 10Mok TS, Steinberg J, Chan AT, et al. Application of the international prognostic index in a study of Chinese patients with non-Hodgkin′s lymphoma and a high incidence of primary extranodal lymphoma. Cancer, 1998, 82:2439-2448.

共引文献15

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部